candesartan has been researched along with carvedilol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Fukuda, Y; Hiraishi, M; Hirata, K; Kaneko, A; Kawai, H; Matsumoto, K; Miyoshi, T; Norisada, K; Ryo, K; Tanaka, H; Tatsumi, K; Tsuji, T; Yamawaki, K | 1 |
| Hanawa, H; Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oda, M; Wada, Y | 1 |
| Kawamura, M; Kobayashi, Y; Munetsugu, Y; Tanno, K | 1 |
| Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R | 1 |
| Han, YL; Liang, XF; Liu, L; Liu, YY; Liu, ZZ; Xie, XD; Zheng, ZD | 1 |
| Al-Shbool, G; Muhailan, M | 1 |
| Chung, WB; Lee, JE; Lee, M; Park, CS; Park, WC; Song, BJ; Youn, HJ | 1 |
| Borley, A; Broom, A; Collins, G; Eddie, L; Everett, RJ; Fletcher, A; Guppy, A; Hall, P; Henriksen, PA; Japp, A; Joshi, SS; Lang, NN; Lewis, S; Lord, S; Maclean, M; MacPherson, IR; McKay, P; McVicars, H; Mills, NL; Newby, DE; Oikonomidou, O; Payne, JR; Primrose, L; Radford, J; Rodriguez, A; Rowntree, C; Singh, T; Stavert, H; Williams, MC | 1 |
1 review(s) available for candesartan and carvedilol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for candesartan and carvedilol
| Article | Year |
|---|---|
Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzimidazoles; Bepridil; Biphenyl Compounds; Carbazoles; Carvedilol; Disease-Free Survival; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Japan; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Propanolamines; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Function Tests; Hong Kong; Humans; Male; Predictive Value of Tests; Prognosis; Propanolamines; Ramipril; Spironolactone; Survival Rate; Tenascin; Tetrazoles; Turkey; Ventricular Remodeling | 2013 |
[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Breast Neoplasms; Carbazoles; Carvedilol; Chemotherapy, Adjuvant; Cyclophosphamide; Electrocardiography; Epirubicin; Female; Fluorouracil; Humans; Mastectomy, Radical; Middle Aged; Propanolamines; Stroke Volume; Tetrazoles; Troponin | 2013 |
Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Antibiotics, Antineoplastic; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Breast Neoplasms; Cardiotoxicity; Carvedilol; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Incidence; Middle Aged; Risk Assessment; Stroke Volume; Tetrazoles; Ventricular Function, Left | 2021 |
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.
Topics: Adrenergic beta-Antagonists; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiotoxicity; Carvedilol; Female; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Troponin I; Ventricular Function, Left | 2023 |
6 other study(ies) available for candesartan and carvedilol
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Researched Medicines Industry (RMI) Code of Practice complaints 2004.
Topics: Advertising; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Codes of Ethics; Dissent and Disputes; Drug Industry; Humans; Losartan; New Zealand; Propanolamines; Tetrazoles | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Exercise-induced left bundle branch block and subsequent mechanical left ventricular dyssynchrony--resolved with pharmacological therapy.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bundle-Branch Block; Carbazoles; Carvedilol; Exercise; Exercise Test; Humans; Male; Middle Aged; Propanolamines; Tetrazoles; Vasodilator Agents; Ventricular Dysfunction, Left | 2011 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Dyspnea; Etanercept; Female; Furosemide; Glucocorticoids; Hand; Heart Failure; Humans; Immunoglobulin G; Lung Diseases, Interstitial; Natriuretic Peptide, Brain; Propanolamines; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Ribonucleosides; Scleroderma, Systemic; Spironolactone; Sulfasalazine; Tetrazoles; Treatment Outcome | 2011 |
Pseudo-Wellens' Syndrome Temporally Associated With Immune Check Point Inhibitors Use.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents, Immunological; Anus Neoplasms; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Carvedilol; Drug Therapy, Combination; Humans; Ipilimumab; Male; Melanoma; Nivolumab; Rectal Diseases; Rectal Neoplasms; Tetrazoles | 2020 |